Histone chaperone Spt6 is required for class switch recombination but not somatic hypermutation
Activation-induced cytidine deaminase (AID) is shown to be essential and sufficient to induce two genetic alterations in the Ig loci: class switch recombination (CSR) and somatic hypermutation (SHM). However, it is still unknown how a single-molecule AID differentially regulates CSR and SHM. Here we...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 108; no. 19; pp. 7920 - 7925 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
10.05.2011
National Acad Sciences |
Subjects | |
Online Access | Get full text |
ISSN | 0027-8424 1091-6490 1091-6490 |
DOI | 10.1073/pnas.1104423108 |
Cover
Loading…
Summary: | Activation-induced cytidine deaminase (AID) is shown to be essential and sufficient to induce two genetic alterations in the Ig loci: class switch recombination (CSR) and somatic hypermutation (SHM). However, it is still unknown how a single-molecule AID differentially regulates CSR and SHM. Here we identified Spt6 as an AID-interacting protein by yeast two-hybrid screening and immunoprecipitation followed by mass spectrometry. Knockdown of Spt6 resulted in severe reduction of CSR in both the endogenous Ig locus in B cells and an artificial substrate in fibroblast cells. Conversely, knockdown of Spt6 did not reduce but slightly enhanced SHM in an artificial substrate in B cells, indicating that Spt6 is required for AID to induce CSR but not SHM. These results suggest that Spt6 is involved in differential regulation of CSR and SHM by AID. |
---|---|
Bibliography: | http://dx.doi.org/10.1073/pnas.1104423108 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 5Present address: Department of Bioscience, Nagahama Institute of Bio-Science and Technology, Shiga 526-0829, Japan. Author contributions: I.-m.O., K.Y., and T.H. designed research; I.-m.O., K.O., M.K., K.Y., S.K., H.N., Y.K., H.T., T.N., and S.-I.I. performed research; H.N. and R.S. contributed new reagents/analytic tools; I.-m.O. and T.H. analyzed data; and I.-m.O. and T.H. wrote the paper. 4Present address: Laboratory for Mucosal Immunity, RIKEN Research Center for Allergy and Immunology, Yokohama 230-0045, Japan. Contributed by Tasuku Honjo, April 5, 2011 (sent for review March 4, 2011) 1Present address: Division of Immune Regulation, Institute for Genome Research, University of Tokushima, 770-8503, Japan. 2Present address: Drug Discovery Research Laboratories, Kyowa Hakko Kirin Co., Ltd., Shizuoka 411-8731, Japan. 3Present address: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA 02115. |
ISSN: | 0027-8424 1091-6490 1091-6490 |
DOI: | 10.1073/pnas.1104423108 |